CTRI/2018/06/014463已完成未知
An Open-label, Multicentric, Non-comparative, observational, Phase-IV Clinical Trial to Evaluate Safety, Tolerability and Efficacy of Injection of Fixed-dose Combination of Camylofin Dihydrochloride 25 mg and Diclofenac Sodium IP 25 mg per ml with Benzyl alcohol IP in the treatment of ColicProtocol ID: Klab/CT/Camy_Diclo/012017 - ANAPAS
Cliniexperts Private Limited0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subject in group of 18-65 years(age of ascent)
- •2. Written and/or witnessed informed consent to participate in the trial was taken prior to initiating the study from parent and/or legally accepted representative
- •3.Patients who had at least six months previous history of confirmed diagnosis of colic
排除标准
- •1. Not willing to sign ICF
- •2. Patients Known or thought to be hypersensitivity, to study drug
- •3. Pregnant and lactating women
- •4. patient with history of hypersensitivity to Camylofin or Diclofenac Sodium
- •5. Patient with prostatic hypertrophy
- •6. Patients with glaucoma
- •7. Patient with mechanical stenosis
- •8. Patients with serious underlying organic disorders
- •9. Patients with paralytic ileus
- •10. Patient with renal and hepatic disorder
- •11. Patient with previous history of heart problems and stroke.
- •12. Participation in another clinical trial in last months and doing study.
研究者
相似试验
已完成
4 期
An observational phase IV clinical trial for treatment of Primary Dysmenorrhoea, Colic of an Oral Tablets of Fixed-dose Combination of Camylofin Dihydrochloride 50 mg and Paracetamol IP 325 without any comparator medicine to be conducted at different centers.CTRI/2019/12/022257Khandelwal laboratories Pvt Ltd
尚未招募
4 期
A Multicentric, open label, non - comparative, prospective evaluation of misuse potential (if any), of Proxyvon (Combination of â?? Propoxyphene Napsylate and Acetaminophen) in Indian patients with mild to moderate pain.CTRI/2011/10/002056Wockhardt Limited900
已完成
2 期
Clinical study on Ampop tablet in healthy participants.CTRI/2023/03/050976Transformative Learning Solutions Private Limited
已完成
4 期
A Prospective, Open-label, Non-comparative, Multi-centric Active PMS to evaluate efficacy and safety of STOMAFIT ORAL LIQUID containing Liquor Bismuth Ammonium Citrate 2.5ml, Belladonna Dry Extract 9mg, Thymol 0.15mg and Menthol 0.2 mg in Gastritis or Gastroesophageal Reflux Disease (GERD)CTRI/2020/03/023787SUNCARE FORMULATIONS PVT LTD200
已完成
4 期
To check the efficacy, safety and tolerability of Sucroferric Oxyhydroxide Chewable Tablet in patients with chronic kidney disease.CTRI/2021/07/034812Emcure Pharmaceuticals Ltd India94